Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rapamycin in ADPKD
NCT00920309Phase 3Terminated
- Sponsor
- Yale University
- Start
- Jun 2009
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of sirolimus in autosomal dominant polycystic kidney disease (ADPKD), sponsored by Yale University. Started Jun 2009; status: terminated.
02
Drugs
sirolimus
03
Conditions
autosomal dominant polycystic kidney disease (ADPKD)
Beyond the preview
Go deeper on NCT00920309.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00920309.